Fennec Pharmaceuticals Inc. (TSX: FRX)
Canada
· Delayed Price · Currency is CAD 8.57
+0.11 (1.30%)
Dec 20, 2024, 3:54 PM EST
Fennec Pharmaceuticals Market Cap
Fennec Pharmaceuticals has a market cap or net worth of CAD 236.13 million as of December 20, 2024. Its market cap has decreased by -30.15% in one year.
Market Cap
236.13M
Enterprise Value
224.32M
Revenue
66.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.57
Market Cap Chart
Since November 12, 2004, Fennec Pharmaceuticals's market cap has increased from 89.84M to 236.13M, an increase of 162.84%. That is a compound annual growth rate of 4.92%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bausch + Lomb Corporation | 9.11B |
| Bausch Health Companies Inc. | 3.95B |
| WELL Health Technologies Corp. | 1.77B |
| dentalcorp Holdings Ltd. | 1.64B |
| Tilray Brands, Inc. | 1.64B |
| Curaleaf Holdings, Inc. | 1.59B |
| Sienna Senior Living Inc. | 1.31B |
| Cronos Group Inc. | 1.07B |